CARDARINE (GW-501516) Dropper

In preclinical and in-vitro research models, GW-501516’s activation of the PPARδ receptor has been studied for its downstream effects on gene expression related to fatty acid oxidation and energy metabolism. Research has explored its influence on shifting cellular metabolism toward fat utilization over glucose, its role in mitochondrial biogenesis within muscle tissue, and its effects on lipid profiles in animal studies, including changes to HDL cholesterol and triglyceride markers. Some studies have also investigated its relationship to endurance-related physiological adaptations at the cellular level, independent of physical activity. It’s worth noting that long-term carcinogenicity findings in rodent studies led to the discontinuation of GW-501516’s clinical development, which is why it remains restricted to laboratory research settings only.